GO:1902958 positive regulation of mitochondrial electron transport, NADH to ubiquinone: Oxidative Phosphorylation Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902958 describes any process that activates or increases the rate of mitochondrial electron transport from NADH to ubiquinone, the reaction catalyzed by respiratory complex I.
• The term is a biological_process child of positive regulation of mitochondrial electron transport and is mechanistically tied to complex I (NADH:ubiquinone oxidoreductase) activity.
• Key molecular players include nuclear-encoded complex I subunits such as NDUFA4L2, NDUFS4, and PINK1-dependent pathways that sustain ATP-linked respiration.
• Enhancing NADH-to-ubiquinone flux with reducing equivalents and ubiquinone can protect neuroblastoma cells from MPP+ toxicity and complex I-IV damage.
• Protein kinase A/CREB signaling upregulates mitochondrial respiratory chain complexes and prevents adriamycin-induced podocyte apoptosis, illustrating physiological positive regulation.
• Dysregulation of this process is implicated in colon cancer oncogenesis, hippocampal synaptic dysfunction, and Parkinson disease-related neurotoxicity.
Description
GO:1902958, positive regulation of mitochondrial electron transport, NADH to ubiquinone, is a Gene Ontology biological_process term that captures any cellular mechanism increasing the frequency, rate, or extent of electron transfer from NADH to ubiquinone within mitochondria. This step is the entry point of the respiratory chain and is executed by complex I, also known as NADH:ubiquinone oxidoreductase, whose activity determines the proton-motive force available for ATP synthesis. Because complex I is the largest respiratory chain enzyme and a major source of reactive oxygen species, its positive regulation is central to cellular bioenergetics and redox balance. Researchers study GO:1902958 to understand how cells match energy supply to demand, how mitochondrial dysfunction contributes to disease, and how pharmacological or genetic interventions can restore respiration. For example, enhancing oxidative phosphorylation with reducing equivalents and ubiquinone mitigates 1-methyl-4-phenylpyridinium (MPP+) toxicity and complex I-IV damage in neuroblastoma cells, directly linking positive regulation of NADH-to-ubiquinone transport to neuroprotection. In parallel, PINK1 gene delivery regulates ATP-related metabolic dysfunction in APP/PS1-N2a cells, showing that upstream regulators can boost respiratory chain performance. From a cancer biology perspective, multidimensional pan-cancer analysis has identified NDUFA4L2 as an oncogenic factor whose expression correlates with altered mitochondrial electron transport, and its verification in colon cancer underscores the clinical relevance of this GO term. Similarly, Ndufs4 ablation decreases synaptophysin expression in the hippocampus, revealing that loss of a complex I subunit impairs neuronal function and highlighting the importance of positive regulation for synaptic health. Together, these findings position GO:1902958 as a convergence point for metabolism, neurodegeneration, and oncology research.
positive regulation of mitochondrial electron transport, NADH to ubiquinone At A Glance
| GO ID | GO:1902958 |
|---|---|
| GO term | positive regulation of mitochondrial electron transport, NADH to ubiquinone |
| Ontology | biological_process |
| Synonym | activation of complex I (NADH to ubiquinone); positive regulation of oxidative phosphorylation, NADH to ubiquinone; upregulation of mitochondrial electron transport, NADH to ubiquinone |
| Major function | Increases the rate of electron transfer from NADH to ubiquinone, thereby supporting proton pumping and ATP synthesis |
| Parent process | positive regulation of mitochondrial electron transport |
| Related enzyme | Respiratory complex I (NADH:ubiquinone oxidoreductase) |
| Representative regulators | NDUFA4L2, NDUFS4, PINK1, PKA/CREB signaling |
| Disease relevance | Colon cancer, hippocampal synaptic dysfunction, Parkinson disease models, podocyte injury |
What Is GO:1902958?
In plain terms, GO:1902958 refers to any process that turns up the speed or strength of the mitochondrial electron transport chain reaction that passes electrons from NADH to ubiquinone. The QuickGO definition states: Any process that activates or increases the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone. This is a biological_process term whose synonyms include activation of complex I (NADH to ubiquinone), positive regulation of oxidative phosphorylation, NADH to ubiquinone, and upregulation of mitochondrial electron transport, NADH to ubiquinone. It is not the electron transport reaction itself but the regulatory input that enhances it, typically through increased complex I abundance, assembly, or catalytic efficiency.
Why Is positive regulation of mitochondrial electron transport, NADH to ubiquinone Important in Cell Biology?
GO:1902958 matters because the NADH-to-ubiquinone step is the rate-limiting entry into oxidative phosphorylation and a decisive factor in cellular ATP supply, redox homeostasis, and survival under stress. Positive regulation of this step can protect neurons from complex I inhibitors such as MPP+, preserve podocyte viability against adriamycin, and support metabolic reprogramming in cancer cells. Conversely, failure to sustain this process contributes to synaptic protein loss after Ndufs4 ablation and to ATP-related metabolic dysfunction in Alzheimer disease models. Understanding its regulators therefore offers therapeutic entry points across neurodegeneration, kidney disease, and oncology.
• Controls the rate of NADH oxidation at complex I, directly influencing proton-motive force and ATP output.
• Protects neuroblastoma cells from MPP+-induced toxicity and complex I-IV damage when enhanced with reducing equivalents and ubiquinone.
• Supports synaptic function, as Ndufs4 ablation reduces synaptophysin expression in the hippocampus.
• Prevents adriamycin-induced podocyte apoptosis via PKA/CREB-mediated upregulation of respiratory chain complexes.
• Is co-opted in cancer, where NDUFA4L2 shows oncogenic value in colon cancer.
• Can be targeted by PINK1 gene delivery to correct ATP-related metabolic dysfunction in APP/PS1-N2a cells.
• Serves as a biomarker axis for pan-cancer mitochondrial reprogramming.
• Provides a mechanistic link between mitochondrial complex I abundance and cellular stress resistance.
• Offers a druggable node for modulating oxidative phosphorylation in metabolic and neurodegenerative disease.
• Is essential for interpreting CRISPR screens that target mitochondrial respiratory chain genes.
What Happens During positive regulation of mitochondrial electron transport, NADH to ubiquinone?
Upstream signal reception and transcriptional activation
In simple terms: The cell first senses a need for more energy and switches on genes that build the respiratory machinery.
Positive regulation of NADH-to-ubiquinone electron transport often begins with signaling cascades that increase the expression of nuclear-encoded complex I subunits. Protein kinase A/CREB signaling upregulates mitochondrial respiratory chain complexes, providing a transcriptional route to enhanced complex I capacity. In cancer contexts, NDUFA4L2 expression is associated with altered mitochondrial electron transport and oncogenic behavior, indicating that transcriptional programs can drive this GO process. PINK1 gene delivery also regulates ATP-related metabolic dysfunction, suggesting that upstream mitochondrial quality-control kinases feed into respiratory chain performance.
Assembly and abundance of complex I (NADH:ubiquinone oxidoreductase)
In simple terms: More working complex I enzymes means more electrons can be passed from NADH to ubiquinone.
The core execution of GO:1902958 requires sufficient levels of assembled complex I. Ndufs4 is a subunit whose ablation decreases synaptophysin expression in the hippocampus, demonstrating that loss of a complex I component compromises neuronal function and by extension the positive regulation of NADH-to-ubiquinone transport. Enhancing oxidative phosphorylation with reducing equivalents and ubiquinone can counteract complex I-IV damage, implying that substrate and cofactor availability cooperate with enzyme abundance to set the rate of this process.
Catalytic enhancement of NADH oxidation and ubiquinone reduction
In simple terms: The enzyme itself works faster, transferring electrons from NADH to ubiquinone more efficiently.
At the catalytic level, positive regulation means an increased frequency or rate of the reaction in which complex I oxidizes NADH and reduces ubiquinone. Experimental evidence shows that supplying reducing equivalents and ubiquinone enhances mitochondrial oxidative phosphorylation and protects against MPP+ toxicity and complex I-IV damage in neuroblastoma cells. This supports the view that substrate availability and coenzyme Q status are direct determinants of the NADH-to-ubiquinone flux captured by GO:1902958.
Coupling to proton pumping and ATP synthesis
In simple terms: Faster electron transfer drives more proton pumping, which ultimately produces more ATP.
Because complex I couples NADH oxidation to proton translocation, positive regulation of NADH-to-ubiquinone transport elevates the proton-motive force and downstream ATP production. PINK1 gene delivery regulates ATP-related metabolic dysfunction in APP/PS1-N2a cells, linking this GO process to cellular ATP status. Similarly, PKA/CREB-dependent upregulation of respiratory chain complexes prevents podocyte apoptosis, indicating that enhanced electron transport supports survival through improved bioenergetics.
Feedback, redox balance, and disease context
In simple terms: The cell monitors the speed of this process and adjusts it to avoid damage or energy failure.
Positive regulation of NADH-to-ubiquinone transport is embedded in feedback loops that balance energy supply with reactive oxygen species production. In colon cancer, NDUFA4L2-mediated changes in mitochondrial electron transport are linked to oncogenic value, suggesting that tumor cells may exploit this process for growth. In neurodegeneration models, enhancing the pathway with ubiquinone and reducing equivalents mitigates complex I-IV damage, while Ndufs4 loss impairs synaptic protein expression, illustrating both protective and pathological outcomes of altered regulation.
Key Genes Involved in GO:1902958 positive regulation of mitochondrial electron transport, NADH to ubiquinone
The following genes and proteins are experimentally implicated in the positive regulation of mitochondrial electron transport from NADH to ubiquinone, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NDUFA4L2 | Complex I-associated subunit linked to mitochondrial electron transport | Pan-cancer analysis and colon cancer oncogenic verification |
| NDUFS4 | Accessory subunit of complex I required for assembly and function | Ablation decreases hippocampal synaptophysin expression |
| PINK1 | Mitochondrial kinase regulating ATP-related metabolic function | Gene delivery corrects metabolic dysfunction in APP/PS1-N2a cells |
| CREB | Transcription factor downstream of PKA signaling | Mediates upregulation of respiratory chain complexes |
| PKA | Protein kinase A signaling component | Prevents adriamycin-induced podocyte apoptosis via complex upregulation |
| NDUFA1 | Complex I subunit | Part of the respiratory chain complexes upregulated by PKA/CREB |
| NDUFB8 | Complex I subunit | Component of mitochondrial respiratory chain complexes |
| NDUFS1 | Core subunit of complex I | Contributes to NADH:ubiquinone oxidoreductase activity |
| NDUFV1 | Core subunit of complex I | Supports NADH oxidation and ubiquinone reduction |
| SDHA | Complex II subunit | Part of mitochondrial electron transport chain affected by MPP+ damage |
| UQCRC1 | Complex III subunit | Complex III component protected by ubiquinone and reducing equivalents |
| COX4I1 | Complex IV subunit | Complex IV component protected in neuroblastoma cells |
| ATP5F1A | ATP synthase subunit | Downstream of proton-motive force generated by complex I |
| MFN2 | Mitochondrial fusion protein | Supports mitochondrial network function relevant to respiration |
| TFAM | Mitochondrial transcription factor | Maintains mitochondrial DNA-encoded respiratory subunits |
| PPARGC1A | Transcriptional coactivator of mitochondrial biogenesis | Can increase respiratory chain capacity |
| SIRT1 | NAD+-dependent deacetylase | Modulates mitochondrial function and stress responses |
| MT-ND1 | Mitochondrially encoded complex I subunit | Essential for complex I catalytic core |
How Is positive regulation of mitochondrial electron transport, NADH to ubiquinone Regulated?
Positive regulation of mitochondrial electron transport, NADH to ubiquinone is controlled at multiple levels. Transcriptional control via PKA/CREB signaling upregulates respiratory chain complexes and protects podocytes from apoptosis. Mitochondrial quality-control kinases such as PINK1 regulate ATP-related metabolic function, and PINK1 gene delivery can correct metabolic dysfunction in APP/PS1-N2a cells. Substrate and cofactor availability also regulate the process: supplying reducing equivalents and ubiquinone enhances oxidative phosphorylation and reduces complex I-IV damage in neuroblastoma cells. In cancer, NDUFA4L2 expression is associated with altered mitochondrial electron transport and oncogenic behavior, indicating that tumor-specific regulatory programs can modulate this GO process. Loss of the complex I subunit Ndufs4 impairs hippocampal synaptophysin expression, showing that subunit composition is a critical regulatory node.
positive regulation of mitochondrial electron transport, NADH to ubiquinone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NDUFA4L2 | Colon cancer oncogenesis and pan-cancer mitochondrial reprogramming | NDUFA4L2 knockout and overexpression in colon cancer cell lines |
| NDUFS4 | Hippocampal synaptic dysfunction and neurodegeneration | Ndufs4 knockout mouse or neuronal cell line |
| PINK1 | Alzheimer disease-related ATP metabolic dysfunction | PINK1 knock-in or overexpression in APP/PS1-N2a cells |
| CREB | Podocyte apoptosis and kidney injury | CREB point-mutation or knockout in podocytes |
| PKA | Adriamycin-induced podocyte apoptosis | PKA overexpression or knockout in podocyte models |
Cancer and mitochondrial reprogramming
NDUFA4L2 has been identified through multidimensional pan-cancer analysis as an oncogenic factor, and its verification in colon cancer links positive regulation of mitochondrial electron transport, NADH to ubiquinone to tumor growth and metabolic adaptation. This suggests that cancer cells may enhance complex I-dependent respiration or remodel it to support biosynthesis and survival.
Neurodegeneration and complex I inhibition
Enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone protects neuroblastoma cells from 1-methyl-4-phenylpyridinium (MPP+) toxicity and complex I-IV damage, directly implicating this GO process in Parkinson disease-related neurotoxicity models. Additionally, Ndufs4 ablation decreases synaptophysin expression in the hippocampus, connecting loss of complex I function to synaptic dysfunction.
Alzheimer disease-related metabolic dysfunction
PINK1 gene delivery regulates ATP-related metabolic dysfunction in APP/PS1-N2a cells, indicating that positive regulation of NADH-to-ubiquinone electron transport may be a therapeutic target in Alzheimer disease models where mitochondrial ATP production is compromised.
Kidney podocyte injury
Protein kinase A/CREB signaling prevents adriamycin-induced podocyte apoptosis via upregulation of mitochondrial respiratory chain complexes, demonstrating that positive regulation of this electron transport step supports podocyte survival and kidney function.
From positive regulation of mitochondrial electron transport, NADH to ubiquinone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a complex I subunit reduce NADH-to-ubiquinone transport? | NDUFS4 or NDUFA4L2 knockout cell lines |
| Can enhancing complex I activity protect against neurotoxins? | Overexpression of complex I subunits or PINK1 in neuroblastoma cells treated with MPP+ |
| Which residues in complex I subunits are required for catalytic enhancement? | Point-mutation knock-in of catalytic or assembly residues |
| How does PKA/CREB signaling upregulate respiratory chain complexes? | CREB knockout or phospho-mutant knock-in in podocytes |
| Can tagged complex I subunits reveal assembly dynamics? | Tagged knock-in of NDUFS4 or NDUFA4L2 for imaging and proteomics |
| Does NDUFA4L2 drive colon cancer growth via mitochondrial electron transport? | NDUFA4L2 overexpression and knockout in colon cancer xenografts |
How to Study the positive regulation of mitochondrial electron transport, NADH to ubiquinone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse respirometry | Oxygen consumption rate and ATP-linked respiration | Quantifying positive regulation of electron transport in live cells |
| Complex I activity assay | NADH oxidation and ubiquinone reduction rates | Validating enzymatic enhancement or inhibition |
| RNA-seq | Transcript levels of respiratory chain genes | Identifying transcriptional upregulation by PKA/CREB |
| Proteomics | Protein abundance of complex I subunits | Confirming assembly and stoichiometry changes |
| TMRM/JC-1 imaging | Mitochondrial membrane potential | Assessing proton pumping and cell health |
| Western blot | Protein expression of NDUFS4, NDUFA4L2, PINK1 | Validating knockout or overexpression models |
| Immunofluorescence | Subcellular localization of complex I subunits | Examining mitochondrial network and assembly |
| CRISPR library screening | Fitness genes affecting mitochondrial respiration | Discovering novel regulators of NADH-to-ubiquinone transport |
Seahorse extracellular flux analysis
Seahorse respirometry measures oxygen consumption rate and extracellular acidification rate, providing a direct readout of mitochondrial electron transport and oxidative phosphorylation capacity. This method is used to quantify how genetic or pharmacological perturbations alter NADH-to-ubiquinone flux in cells such as neuroblastoma or podocytes.
Complex I activity assays
Spectrophotometric assays monitor NADH oxidation and ubiquinone reduction to determine complex I enzymatic activity. These assays are essential for validating whether a candidate regulator positively regulates the NADH-to-ubiquinone step, as demonstrated in studies of MPP+ toxicity and ubiquinone protection.
Transcriptomic and proteomic profiling
RNA-seq and quantitative proteomics reveal changes in the expression of nuclear-encoded respiratory chain subunits following signaling activation or disease modeling. PKA/CREB-dependent upregulation of respiratory chain complexes was characterized using such approaches, and pan-cancer analyses of NDUFA4L2 integrated multi-omics data.
Live-cell imaging and mitochondrial membrane potential
Fluorescent dyes such as TMRM or JC-1 measure mitochondrial membrane potential, an indirect indicator of proton pumping by complex I. Imaging of PINK1-delivered cells and Ndufs4-ablated neurons can reveal functional consequences of altered NADH-to-ubiquinone transport.
How CRISPR Can Be Used to Study GO:1902958 positive regulation of mitochondrial electron transport, NADH to ubiquinone
Knockout
CRISPR knockout of complex I subunits such as NDUFS4 or NDUFA4L2 can abolish or reduce NADH-to-ubiquinone electron transport, providing causal evidence for their role in GO:1902958. Ndufs4 ablation in models decreases synaptophysin expression, demonstrating the functional impact of losing a positive regulator. Knockout of NDUFA4L2 in colon cancer cells can test its oncogenic dependency on mitochondrial electron transport.
Point Mutation
Point-mutation knock-in allows precise interrogation of catalytic residues or phosphorylation sites within complex I subunits or upstream regulators such as CREB. For example, mutating PKA/CREB phosphorylation sites can determine whether signaling-dependent upregulation of respiratory chain complexes is required for podocyte survival. Such models help distinguish catalytic enhancement from changes in protein abundance.
Knock-in
Tagged knock-in of NDUFS4, NDUFA4L2, or PINK1 enables live-cell imaging, immunoprecipitation, and proteomic analysis of complex I assembly and turnover. These models are valuable for tracking how positive regulation alters the composition and dynamics of the respiratory chain in response to stress or signaling.
Overexpression
CRISPR activation or cDNA overexpression of PINK1, NDUFA4L2, or complex I subunits can boost NADH-to-ubiquinone transport and test protective effects. PINK1 gene delivery regulates ATP-related metabolic dysfunction in APP/PS1-N2a cells, illustrating how overexpression can rescue bioenergetic deficits. Similarly, enhancing complex I components may protect against MPP+ toxicity.
How EDITGENE Supports positive regulation of mitochondrial electron transport, NADH to ubiquinone Research
Researchers studying positive regulation of mitochondrial electron transport, NADH to ubiquinone-related genes often need to determine whether a candidate gene is causally involved in enhancing complex I activity, whether a specific residue is required for that enhancement, or whether overexpression can rescue a disease phenotype. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mitochondrial electron transport, NADH to ubiquinone research.
Frequently Asked Questions About positive regulation of mitochondrial electron transport, NADH to ubiquinone
What is GO:1902958?
GO:1902958 is the Gene Ontology biological_process term for positive regulation of mitochondrial electron transport, NADH to ubiquinone, meaning any process that activates or increases the rate of electron transfer from NADH to ubiquinone, typically at complex I.
What genes are involved in positive regulation of mitochondrial electron transport, NADH to ubiquinone?
Key genes include NDUFA4L2, NDUFS4, PINK1, and signaling components such as PKA and CREB, all of which have been experimentally linked to this process.
Which enzyme catalyzes NADH to ubiquinone electron transport?
Respiratory complex I, also known as NADH:ubiquinone oxidoreductase, catalyzes the transfer of electrons from NADH to ubiquinone, and its activity is the target of positive regulation in GO:1902958.
How is positive regulation of complex I measured experimentally?
Complex I activity assays measuring NADH oxidation and ubiquinone reduction, together with Seahorse respirometry, are standard methods to quantify this process.
What diseases are linked to altered NADH-to-ubiquinone electron transport?
Colon cancer, hippocampal synaptic dysfunction, Parkinson disease-related neurotoxicity, Alzheimer disease metabolic dysfunction, and podocyte injury have all been associated with changes in this pathway.
Can enhancing mitochondrial oxidative phosphorylation protect neurons?
Yes, studies show that supplying reducing equivalents and ubiquinone enhances oxidative phosphorylation and protects neuroblastoma cells from MPP+ toxicity and complex I-IV damage.
What is the role of NDUFA4L2 in cancer?
NDUFA4L2 has been identified as an oncogenic factor in pan-cancer analysis and verified in colon cancer, where it is associated with altered mitochondrial electron transport.
How does PINK1 regulate ATP-related metabolism?
PINK1 gene delivery regulates ATP-related metabolic dysfunction in APP/PS1-N2a cells, suggesting it supports mitochondrial electron transport and energy production.
What happens when Ndufs4 is lost?
Ndufs4 ablation decreases synaptophysin expression in the hippocampus, indicating that loss of a complex I subunit impairs neuronal function.
How can CRISPR help study GO:1902958?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models allow causal testing of genes and residues that regulate NADH-to-ubiquinone electron transport.
Conclusion
GO:1902958, positive regulation of mitochondrial electron transport, NADH to ubiquinone, is a central biological_process that governs the rate of electron entry into the respiratory chain at complex I. Experimental evidence links its regulators, including NDUFA4L2, NDUFS4, PINK1, and PKA/CREB signaling, to cancer, neurodegeneration, and kidney cell survival. Understanding how this process is enhanced or impaired provides a foundation for therapeutic strategies targeting mitochondrial bioenergetics. By combining precise CRISPR models with functional assays such as respirometry and complex I activity measurements, researchers can dissect the causal contributions of individual genes and residues to this process. EDITGENE supports these efforts with knockout, knock-in, point-mutation, overexpression, and library screening services tailored to mitochondrial research.
References
- 1. Yi J et al.. 2025. A multidimensional pan-cancer analysis of NDUFA4L2 and verification of the oncogenic value in colon cancer.. FASEB J 39(1):e70300 PMID: 39792315
- 2. Shil SK et al.. 2021. Ndufs4 ablation decreases synaptophysin expression in hippocampus.. Sci Rep 11(1):10969 PMID: 34040028
- 3. Mazzio EA et al.. 2004. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells.. Biochem Pharmacol 67(6):1167-84 PMID: 15006552
- 4. Yu S et al.. 2024. Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells.. Molecules 29(9) PMID: 38731398
- 5. Xie K et al.. 2018. Protein Kinase A/CREB Signaling Prevents Adriamycin-Induced Podocyte Apoptosis via Upregulation of Mitochondrial Respiratory Chain Complexes.. Mol Cell Biol 38(1) PMID: 29038164
